{"url_path":"/sec/tnya/8-k/2026-06-29/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1858848/0001193125-26-286957-index.html","accession_number":"0001193125-26-286957","cik":"0001858848","ticker":"TNYA","issuer_name":"Tenaya Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1858848/0001193125-26-286957-index.html","primary_entity_key":"0001858848","primary_entity_name":"Tenaya Therapeutics, Inc."},"word_count":97,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\nNo.\n\n \n\nDescription\n\n \n\n \n\n10.1\n\n \n\n[Offer Letter by and between the Company and Eric Hyllengren, dated as of June 18, 2026](tnya-ex10_1.htm)\n\n99.1\n\n \n\n[Press Release dated June 29, 2026](tnya-ex99_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nTENAYA THERAPEUTICS, INC.\n\n \n\n \n\n \n\nBy:\n\n \n\n \n\n/s/ Jennifer Drimmer Rokovich\n\n \n\n \n\n \n\n \n\nJennifer Drimmer Rokovich\n\n \n\n \n\n \n\n \n\nGeneral Counsel and Secretary\n\nDate: June 29, 2026"}